Abstract

Urinary Bladder Carcinoma Pattern at Urology Minia University Hospital

Highlights

  • Bladder cancer is one of the most common malignancies occurring worldwide

  • Patients and Methods Study Design: Our study is a prospective clinical study conducted on 120 patients who attended to our outpatient clinic at Nephrology and Urology Minia University Hospital in the period from March 2020 to March 2021

  • Our study revealed that about 28 (77.78%) of squamous cell carcinoma (SCC) mases were high grade tumors, 43 (55.12%) of Transitional cell carcinoma (TCC) mases were high grade tumors and 4 (66.67%) of adenocarcinoma mases are high grade tumors and on the other hand, 35 (44.88%) of TCC were low grade tumor, 2 (33.3%) of adenocarcinoma were low grade tumors and 8 (22.22%) of SCC were low grade tumors (Table 2)

Read more

Summary

Introduction

Bladder cancer is one of the most common malignancies occurring worldwide. Bladder cancer develops predominantly in males with a ratio male: female (3:1). Urothelial cell carcinoma (UCC) is the predominant bladder tumor (>90%) of cases. Others may present with irritative symptoms such as dysuria, frequency or urgency. Symptoms of metastases such as bone or flank pain are rare. (Hodges SC 2017) (DeGEORGE et al, 2017). Treatment of bladder cancer is based on the tumor's clinical stage. Stage means how deep it is thought to have grown into the bladder wall and spread beyond the bladder. Other factors, such as the size of the tumor, grade and performance state. Treatment options are TUR and intra vesicle injection of BCG, mitomycin or chemotherapy for stage 0, for invasive bladder cancer not metastatic, radical cystectomy is the standard treatment, followed by chemotherapy and radiotherapy. (DeGEORGE et al, 2017)

Patients and Methods
Results
Discussion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.